These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 37466774)
1. Development of the Placenta and Brain Are Affected by Selective Serotonin Reuptake Inhibitor Exposure During Critical Periods. Bravo K; González-Ortiz M; Beltrán-Castillo S; Cáceres D; Eugenín J Adv Exp Med Biol; 2023; 1428():179-198. PubMed ID: 37466774 [TBL] [Abstract][Full Text] [Related]
3. Biomarkers of Affective Dysregulation Associated with In Utero Exposure to EtOH. Darbinian N; Merabova N; Tatevosian G; Morrison M; Darbinyan A; Zhao H; Goetzl L; Selzer ME Cells; 2023 Dec; 13(1):. PubMed ID: 38201206 [TBL] [Abstract][Full Text] [Related]
4. Peripheral and central neurochemical effects of the selective serotonin reuptake inhibitors (SSRIs) in humans and nonhuman primates: assessing bioeffect and mechanisms of action. Anderson GM Int J Dev Neurosci; 2004; 22(5-6):397-404. PubMed ID: 15380838 [TBL] [Abstract][Full Text] [Related]
5. Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breastfeeding mother-infant pairs. Epperson CN; Jatlow PI; Czarkowski K; Anderson GM Pediatrics; 2003 Nov; 112(5):e425. PubMed ID: 14595087 [TBL] [Abstract][Full Text] [Related]
6. [Fluoxetine: an update of its use in major depressive disorder in adults]. Gourion D; Perrin E; Quintin P Encephale; 2004; 30(4):392-9. PubMed ID: 15597466 [TBL] [Abstract][Full Text] [Related]
7. Alterations in Resting-State Networks Following In Utero Selective Serotonin Reuptake Inhibitor Exposure in the Neonatal Brain. Rotem-Kohavi N; Williams LJ; Virji-Babul N; Bjornson BH; Brain U; Werker JF; Grunau RE; Miller SP; Oberlander TF Biol Psychiatry Cogn Neurosci Neuroimaging; 2019 Jan; 4(1):39-49. PubMed ID: 30292808 [TBL] [Abstract][Full Text] [Related]
8. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. Eke AC; Saccone G; Berghella V BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775 [TBL] [Abstract][Full Text] [Related]
9. Maternal serotonin: implications for the use of selective serotonin reuptake inhibitors during gestation†. Domingues RR; Wiltbank MC; Hernandez LL Biol Reprod; 2023 Jul; 109(1):17-28. PubMed ID: 37098165 [TBL] [Abstract][Full Text] [Related]
10. Perinatal selective serotonin reuptake inhibitor exposure: impact on brain development and neural plasticity. Pawluski JL Neuroendocrinology; 2012; 95(1):39-46. PubMed ID: 21893935 [TBL] [Abstract][Full Text] [Related]
12. Perinatal exposure to the selective serotonin reuptake inhibitor citalopram alters spatial learning and memory, anxiety, depression, and startle in Sprague-Dawley rats. Sprowles JL; Hufgard JR; Gutierrez A; Bailey RA; Jablonski SA; Williams MT; Vorhees CV Int J Dev Neurosci; 2016 Nov; 54():39-52. PubMed ID: 27591973 [TBL] [Abstract][Full Text] [Related]
13. Developmental effects of SSRIs: lessons learned from animal studies. Borue X; Chen J; Condron BG Int J Dev Neurosci; 2007 Oct; 25(6):341-7. PubMed ID: 17706396 [TBL] [Abstract][Full Text] [Related]
14. New Insights into How Serotonin Selective Reuptake Inhibitors Shape the Developing Brain. Gingrich JA; Malm H; Ansorge MS; Brown A; Sourander A; Suri D; Teixeira CM; Caffrey Cagliostro MK; Mahadevia D; Weissman MM Birth Defects Res; 2017 Jul; 109(12):924-932. PubMed ID: 28714607 [TBL] [Abstract][Full Text] [Related]
15. Maternal use of selective serotonin reuptake inhibitors, fetal growth, and risk of adverse birth outcomes. El Marroun H; Jaddoe VW; Hudziak JJ; Roza SJ; Steegers EA; Hofman A; Verhulst FC; White TJ; Stricker BH; Tiemeier H Arch Gen Psychiatry; 2012 Jul; 69(7):706-14. PubMed ID: 22393202 [TBL] [Abstract][Full Text] [Related]
16. Central nervous system effects of prenatal selective serotonin reuptake inhibitors: sensing the signal through the noise. Gur TL; Kim DR; Epperson CN Psychopharmacology (Berl); 2013 Jun; 227(4):567-82. PubMed ID: 23681158 [TBL] [Abstract][Full Text] [Related]
17. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials. Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus. Delaney C; Gien J; Grover TR; Roe G; Abman SH Am J Physiol Lung Cell Mol Physiol; 2011 Dec; 301(6):L937-44. PubMed ID: 21908589 [TBL] [Abstract][Full Text] [Related]
19. Serotonin hypothesis of autism: implications for selective serotonin reuptake inhibitor use during pregnancy. Harrington RA; Lee LC; Crum RM; Zimmerman AW; Hertz-Picciotto I Autism Res; 2013 Jun; 6(3):149-68. PubMed ID: 23495208 [TBL] [Abstract][Full Text] [Related]
20. The effects of maternal antidepressant use on offspring behaviour and brain development: Implications for risk of neurodevelopmental disorders. Millard SJ; Weston-Green K; Newell KA Neurosci Biobehav Rev; 2017 Sep; 80():743-765. PubMed ID: 28629713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]